Oxford COVID shot 'less effective on South Africa variant'
AstraZeneca said that its vaccine developed with the University of Oxford appeared to offer limited protection against mild disease caused by the South African variant of COVID-19.
Suscribirse a:
Enviar comentarios (Atom)
Comentarios
Publicar un comentario
Leave a comment. Thanks!
Comentarios de Facebook